3/18
11:42 am
dftx
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names [Yahoo! Finance]
Low
Report
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names [Yahoo! Finance]
3/15
06:09 am
dftx
Definium Therapeutics Teases Phase III DT120 Data for Anxiety, Depression at Leerink Conference [Yahoo! Finance]
Low
Report
Definium Therapeutics Teases Phase III DT120 Data for Anxiety, Depression at Leerink Conference [Yahoo! Finance]
3/9
04:01 pm
dftx
Definium Therapeutics Announces New Employee Inducement Grants
Medium
Report
Definium Therapeutics Announces New Employee Inducement Grants
3/2
09:04 am
dftx
Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.
Low
Report
Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.
2/28
03:23 pm
dftx
Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]
Low
Report
Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]
2/26
11:40 pm
dftx
Definium Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Definium Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
04:14 pm
dftx
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates [Yahoo! Finance]
Low
Report
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates [Yahoo! Finance]
2/26
04:01 pm
dftx
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
Low
Report
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
2/25
06:24 am
dftx
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
2/24
07:21 am
dftx
Definium Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Definium Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
2/24
07:01 am
dftx
Definium Therapeutics to Participate at Upcoming Investor Conferences
Low
Report
Definium Therapeutics to Participate at Upcoming Investor Conferences
2/23
06:01 pm
dftx
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium
Report
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/19
04:13 pm
dftx
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
Low
Report
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
2/19
04:01 pm
dftx
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
Low
Report
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
2/18
09:53 pm
dftx
Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III [Yahoo! Finance]
Low
Report
Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III [Yahoo! Finance]
2/2
04:00 pm
dftx
Definium Therapeutics Announces New Employee Inducement Grants
Low
Report
Definium Therapeutics Announces New Employee Inducement Grants
2/2
10:57 am
dftx
Definium Therapeutics (NASDAQ:DFTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Definium Therapeutics (NASDAQ:DFTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
2/1
12:32 am
dftx
Roger Adsett Joins Definium As Commercial Focus Meets Trial Milestones [Yahoo! Finance]
Medium
Report
Roger Adsett Joins Definium As Commercial Focus Meets Trial Milestones [Yahoo! Finance]
2/1
12:32 am
dftx
Did Adding Biopharma Veteran Roger Adsett to the Board Just Shift Definium Therapeutics' (DFTX) Investment Narrative? [Yahoo! Finance]
Medium
Report
Did Adding Biopharma Veteran Roger Adsett to the Board Just Shift Definium Therapeutics' (DFTX) Investment Narrative? [Yahoo! Finance]
1/31
07:45 am
dftx
Definium Therapeutics (NASDAQ:DFTX) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Medium
Report
Definium Therapeutics (NASDAQ:DFTX) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
1/29
07:03 pm
dftx
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Low
Report
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
1/29
10:04 am
dftx
Definium Therapeutics (NASDAQ:DFTX) was given a new $37.00 price target on by analysts at Robert W. Baird.
Low
Report
Definium Therapeutics (NASDAQ:DFTX) was given a new $37.00 price target on by analysts at Robert W. Baird.
1/29
07:00 am
dftx
Definium Therapeutics Appoints Roger Adsett to Board of Directors
Low
Report
Definium Therapeutics Appoints Roger Adsett to Board of Directors
1/26
04:46 pm
dftx
Definium Therapeutics Announces New Employee Inducement Grants [Yahoo! Finance]
Medium
Report
Definium Therapeutics Announces New Employee Inducement Grants [Yahoo! Finance]
1/26
04:01 pm
dftx
Definium Therapeutics Announces New Employee Inducement Grants
Medium
Report
Definium Therapeutics Announces New Employee Inducement Grants